Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
Patents for C07D 295 - Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms (34,005)
11/2003
11/11/2003CA2133579C Synergistic composition and process for selective weed control
11/06/2003WO2003091247A2 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/06/2003WO2003090678A2 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
11/06/2003WO2003079970A3 4-(diarylmethyl)-1-piperazinyl derivatives
11/06/2003WO2003066889A3 Assay for acytyltransferase or deacetylase activity
11/06/2003WO2003016270A3 Selective estrogen receptor modulators
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003WO2002051983A3 Novel compounds and compositions as cathepsin inhibitors
11/06/2003US20030208079 Heterocyclic amines such as (2S,3S)-3-((1R)-6-methoxy-1-methyl -1-trifluoromethylisochroman-7-yl)methylamino-2-phenyl piperidine, used as analgesics, antiinflammatory agents, or for proph7ylaxis of cardiovascular disorders
11/06/2003US20030208075 Process for making chiral 1,4-disubstituted piperazines
11/06/2003US20030208074 Reacting protected heterocyclic amines in the presence of bases and solvents, to form chemical intermeadiates used as chemokine receptor antagonists
11/06/2003US20030207939 Novel 3-substituted urea derivatives and medicinal use thereof
11/06/2003US20030207934 Such as ((S)-1-benzyl-2-oxo-but-3-enyl)-carbamic acid tert-butyl ester; for treating human immunodeficiency virus; antimalarial agents
11/06/2003US20030207919 For treating, preventing, reducing inflammation, pain, fever,gastrointestinal disorders; decreasing gastrointestinal, renal and other toxicities resulting from use of nonsteroidal antiinflammatory drugs; multiplicity of compounds
11/06/2003US20030207895 Tissue factor antagonists and methods of use thereof
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207872 Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
11/06/2003US20030207866 Drugs useful for the treatment of diseases or disorders of the central nervous system.
11/06/2003US20030207864 Novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular
11/06/2003US20030207861 Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
11/06/2003US20030207344 Ethers and esters of cyanohydrins that contain optically detectable moieties are highly effective for detecting, monitoring, and measuring the activity of enzymes that cause the cleavage of certain types of substrates. The cyanohydrins
11/06/2003US20030206935 P-(alpha-hydroxyhydrocarbylcarbonylamino)-substituted benzoic acid esters; reducing and/or slowing down the loss of head hair and/or body hair, or inducing and/or stimulating its growth.
11/06/2003CA2483725A1 Antileishmanial dinitroaniline sulfonamides with activity against parasite tubulin
11/06/2003CA2483314A1 Piperidinyl-and piperazinyl-sulfonylmethyl hydroxamic acids and their use as protease inhibitors
11/05/2003EP1358172A2 Amino ceramide-like compounds and therapeutic methods of use
11/05/2003EP1358171A2 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
11/05/2003EP1358170A1 Process for preparing higher primary alkanols
11/05/2003EP1358169A2 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase
11/05/2003EP1358150A1 Use of bicyclic esters or amides for the treatment of diseases responsive to enhanced potassium channel activity
11/05/2003EP1357909A1 Il-8 receptor antagonists
11/05/2003EP1165494B1 Hsv primase inhibitors
11/05/2003EP1066246B1 Novel cationic couplers and their use for oxidation dyeing
11/05/2003CN1454203A Substituted nitrated catechols their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them
11/05/2003CN1454084A Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion
11/05/2003CN1453272A Novel morpholone derivative and its prepn and use
11/05/2003CN1453265A Aromatic amino acid derivative and its prepn process and medicinal use
11/05/2003CN1126749C Granular N-alkyl ammonium acetonitrile composition
11/04/2003US6642273 Dermatology, vision defects, cardiovascular disorders, antiinflammatory
11/04/2003US6642239 Dipeptide nitrile cathepsin K inhibitors
11/04/2003US6642233 Strong affinity and high selectivity for the human NK1 receptors of substance P.
11/04/2003US6642226 Such as cis-(3,5-bis-trifluoromethyl-phenyl)-(4-(4-methyl-piperazin-1-yl),-3-phenyl -piperidin-1-yl)-methanone; for treatment of diseases related to neurokinin receptors
11/04/2003US6641871 Electrooptical display
11/04/2003CA2257322C Thiazole derivatives
10/2003
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003WO2003020287A3 Methods for the treatment of chronic pain anc compositions therefor
10/30/2003WO2002069901A3 Cathepsin cysteine protease inhibitors
10/30/2003WO2002064136A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
10/30/2003US20030204089 Enantiomers of 1-[(4-chlorophenyl) phenylmethyl]-4-[(4-methylphenyl) sulfonyl] piperazine
10/30/2003US20030204085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
10/30/2003US20030204034 Forming a mixture of one or more monomers, at least one free radical source and a control agent and subjecting mixture to polymerization
10/30/2003US20030203975 Such as complex of amino acid/peptide and 1-(2-hydroxyethylamino)anthracene-9,10-dione
10/30/2003US20030203919 Dipeptide nitrile cathepsin K inhibitors
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/30/2003US20030203906 Novel substituted diamine derivatives useful as motlin antagonists
10/29/2003EP1357117A2 Novel aminoketone derivatives and preparation process and uses of the same as photoinitiators
10/29/2003EP1355894A1 Amidinophenylalanine derivatives as thrombin inhibitors
10/29/2003EP1355893A2 Antiangiogenic compounds and an assay for inhibitors of cell invasion
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355873A1 Pleuromutilin derivatives with antimicrobial activity
10/29/2003EP1089964B1 Hydrazine derivatives
10/29/2003EP0946526B1 Macrocyclic metal complex carboxylic acids, use and method for the production thereof
10/29/2003CN1452483A IL-8 receptor antagonists
10/28/2003US6639109 Process for production of thioalkylamine derivatives
10/28/2003US6638980 Inhibitors of factor Xa
10/28/2003US6638967 Pyrrole, furan, thiofuran and phenyl derivatives; inhibition of histamine H3 receptor activity; for example, 1-((4-(4-Pyrrolidin-1-ylmethyl-phenyl)-thien-2-yl)methyl)-pyrrolidine
10/28/2003US6638952 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds
10/28/2003US6638931 Aminoguanidines and alkoxyguanidines as protease inhibitors
10/28/2003US6638927 Melanocortin-4 receptor (MC4-R) agonists; treating obesity or diabetes; 4-((N-cyclohexyl-3,5-dimethyl-piperazine-1-carboximidoyl)-amino)-N-(2-(2,4 -dichlorophenyl) -ethyl)-benzamide for example
10/28/2003US6638922 4-dedimethylaminotetracycline derivatives
10/28/2003CA2249786C Difluoro statone analogs
10/28/2003CA2221114C Atherosclerosis treatment
10/23/2003WO2003087127A2 Antimicrobial compounds against staphylococci, mycobacteria, and other infectious agents
10/23/2003WO2003087074A1 Phenol compound, process for producing the same, and intermediate therefor
10/23/2003WO2003087066A1 α,β-UNSATURATED HYDROXAMIC ACID DERIVATIVES AND THEIR USE AS HISTONE DEACETYLASE INHIBITORS
10/23/2003WO2003087057A1 Benzamide derivatives useful as histone deacetylase inhibitors
10/23/2003WO2003087046A1 Novel aminotetraline compounds for use in mch receptor related disorders
10/23/2003WO2003087045A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/23/2003WO2003087044A2 Novel carboxamide compounds for use in mch receptor related disorders
10/23/2003WO2003087037A1 Substituted aryl amides
10/23/2003WO2003086397A1 Medicine for treating cancer
10/23/2003WO2003086393A1 3-aza- and 1,4-diaza-bicyclo[4.3.0]nonanes, and methods of use thereof
10/23/2003WO2003086325A2 Cyanamides useful as reversible inhibitors of cysteine proteases
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2003055848A3 Urea derivatives as vr1- antagonists
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003US20030199561 Boronic ester and acid compounds, synthesis and uses
10/23/2003US20030199550 Cyclohexane derivatives containing amine or amine oxide, useful for treating hypercholesterolemia and hyperlipemia
10/23/2003US20030199508 Compounds and their therapeutic use
10/23/2003US20030199505 Anticoagulants as inhibitors of factor Xa; treating thrombosis, or aftertreatment following angioplasty and coronary bypass operations
10/23/2003US20030199504 Anticoagulants as inhibitors of factor Xa; treating thrombosis, or aftertreatment following angioplasty and coronary bypass operations
10/23/2003US20030199499 Novel guanidinobenzamides
10/23/2003US20030199478 For modulating tyrosine kinase signal transduction in order to regulate, modulate and/or inhibit abnormal cell proliferation
10/23/2003US20030199453 Small molecule inhibitors of secretion of proteins encoded by ARE-mRNAs
10/23/2003CA2482341A1 Novel methoxybenzamide compounds for use in mch receptor related disorders
10/23/2003CA2480856A1 Substituted aryl amides
10/23/2003CA2480832A1 Nitric oxide donors, compositions and methods of use
10/23/2003CA2477692A1 Cyanamides useful as reversible inhibitors of cysteine proteases
10/22/2003EP1354887A1 Ligands for metals and improved metal-catalyzed processes based thereon
10/22/2003EP1353917A2 Novel process for the synthesis of 5-(4-fluorophenyl)-1-(2-((2r, 4r)-4-hydroxy -6-oxo-tetrahydro-pyran-2-yl)-ethyl)-2-isopropyl-4-phenyl-1h-pyrrole-3-carboxylic acid phenylamide
10/22/2003EP1353898A2 Compounds to treat alzheimer's disease
1 ... 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 ... 341